Month: June 2025

– First use of camel hemoglobin as a universal oxygen carrier – Unique properties make it an ideal ingredient for oxygen transport BOSTON, MASSACHUSETTS, June 18, 2025 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke, Alzheimer’s disease, and viruses, has a secured a GMP quality source of camel hemoglobin with help from the Heme Foundation. The Heme foundation, dedicated to solving the worlds blood shortages, is partnered with Bioxytran in a $10 million Joint Venture (JV) to develop a Universal Oxygen Carrier (UOC). Through this collaboration, Bioxtyran now has a long-term source of GMP quality camel hemoglobin – a crucial component for advancing this innovative oxygen transport system. Growing interest in the UOC project is expected...

GREENWICH, CONNECTICUT, June 18, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (the “Company”), an American developer of battery-grade lithium products, today announced the closing of its previously announced underwritten public offering. Gross proceeds to the Company were approximately $4.3 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering closed on June 18, 2025. The offering consisted of 21,500,000 shares of common stock (“Common Stock”). The public offering price per share of Common Stock was $0.20. In addition, the Company has granted Aegis Capital Corp. (“Aegis”) a 45-day option to purchase up to an additional 3,225,000 shares of Common Stock, representing 15.0% of the number of shares of Common Stock sold in the offering solely to cover over-allotments,...

RISHON LE ZION, Israel, June 18, 2025 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), a leading integrator of supply chain technologies, announced today that its Supply Chain division has secured a $1.1 million order from a new Israeli customer, with delivery scheduled for the third quarter of 2025. Avidan Zelicovsky, BOS President, stated: “Gaining this new customer highlights the strength of our Supply Chain Division in integrating franchised electromechanical components into the products of leading defense and high-tech companies. Our engineering team collaborates closely with our customers’ R&D departments to ensure seamless integration into their innovative products, supporting long-term revenue growth for us as these products move into production.” Gadi...

Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction and progression to heart failure with preserved ejection fraction (“HFpEF”) Hypertensive heart disease represents over 7.7 million U.S. patients, the same population with hypertension and elevated cardiovascular risk cited in the recent FDA Breakthrough Device Designation (“BDD”) for AVIM therapyNEW HOPE, Pa., June 18, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the presentation of key clinical insights into the role of AVIM therapy for the...

The annual general meeting of Icelandic Salmon AS (the “Company”) was held on 18 June 2025 at 11:00 (CEST). All resolutions were approved as proposed by the board. Please find the minutes including appendices enclosed. The documents are also made available on the Company’s website https://arnarlax.is/investors/. For more information, please contact: Björn Hembre, CEO. Tel: +47 913 47 432 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentAGM Minutes 2025 – Icelandic Salmon AS

MELVILLE, N.Y., June 18, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to announce that its Chief Executive Officer, Lance Alstodt, will be interviewed during the Benzinga All-Access Show today, Wednesday, June 18, 2025, at 10:50 a.m. Eastern time. Benzinga All-Access Show Date: Wednesday, June 18, 2025 Time: 10:50 a.m. Eastern Time Live Webcast: https://youtube.com/live/VaTuqmybnfY?feature=share The interview will also be archived on the Investors section of the Company’s website. About BioRestorative Therapies, Inc. BioRestorative (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Company”) is pleased to announce that it has closed its previously announced and upsized underwritten public offering of common shares in the capital of the Company (the “Shares”) at a price of $13.35 per Share, including the full exercise of the over-allotment option, for aggregate gross proceeds of approximately $143,750,000 (the “Offering”). Desjardins Capital Markets acted as sole bookrunner, along with National Bank Financial Inc. and BMO Capital Markets as co-lead underwriters, with a syndicate of underwriters comprised of CIBC World Markets Inc., Raymond James Ltd., Stifel Nicolaus Canada Inc., Scotia Capital Inc.,...

New York, June 18, 2025 (GLOBE NEWSWIRE) — Eureka Acquisition Corp (the “Company”) (Nasdaq: EURK), a blank check company, today announced that its previously announced extraordinary general meeting in lieu of an annual general meeting of shareholders (the “Extraordinary General Meeting”) will be postponed from 9:00 a.m. Eastern Time on June 20, 2025 to 9:00 a.m. Eastern Time on June 25, 2025 (the “Postponement”) to allow the Company additional time to engage with shareholders.  The Extraordinary General Meeting is to be held for the purpose of considering and voting on, among other proposals, a proposal to amend the Company’s current charter to provide that the Company has until July 3, 2025 to complete a business combination and may elect to extend up to twelve times, each by a one-month extension, for a total of up to twelve...